| Drug-facilitated sexual assaults (DFSA): a serious underestimated issue. FP Busardò, MR Varì, A Di Trana, S Malaca, J Carlier, NM Di Luca European Review for Medical & Pharmacological Sciences 23 (24), 2019 | 80 | 2019 |
| A review of synthetic cathinone–related fatalities from 2017 to 2020 N La Maida, A Di Trana, R Giorgetti, A Tagliabracci, FP Busardò, ... Therapeutic drug monitoring 43 (1), 52-68, 2021 | 63 | 2021 |
| Consequences of COVID-19 lockdown on the misuse and marketing of addictive substances and new psychoactive substances A Di Trana, J Carlier, P Berretta, S Zaami, G Ricci Frontiers in psychiatry 11, 584462, 2020 | 62 | 2020 |
| Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases G Mannocchi, A Di Trana, A Tini, S Zaami, M Gottardi, S Pichini, ... Analytical and Bioanalytical Chemistry 412, 5125-5145, 2020 | 59 | 2020 |
| A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid AD Trana, G Mannocchi, F Pirani, NL Maida, M Gottardi, S Pichini, ... Journal of Analytical Toxicology 44 (8), 769-783, 2020 | 44 | 2020 |
| Biomedical analysis of New Psychoactive Substances (NPS) of natural origin AFL Faro, A Di Trana, N La Maida, A Tagliabracci, R Giorgetti, ... Journal of Pharmaceutical and Biomedical Analysis 179, 112945, 2020 | 42 | 2020 |
| In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites A Di Trana, P Brunetti, R Giorgetti, E Marinelli, S Zaami, FP Busardo, ... Talanta 235, 122740, 2021 | 30 | 2021 |
| Testing unconventional matrices to monitor for prenatal exposure to heroin, cocaine, amphetamines, synthetic cathinones, and synthetic opioids J Carlier, N La Maida, A Di Trana, MA Huestis, S Pichini, FP Busardò Therapeutic Drug Monitoring 42 (2), 205-221, 2020 | 23 | 2020 |
| Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance FP Busardò, A Di Trana, E Montanari, S Mauloni, A Tagliabracci, ... Forensic science international 301, 137-141, 2019 | 23 | 2019 |
| The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs F Negro, A Di Trana, S Marinelli ACTA BIOMEDICA 92 (6), 1-3, 2022 | 19 | 2022 |
| 3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining J Carlier, D Berardinelli, E Montanari, A Sirignano, A Di Trana, ... Journal of Chromatography B 1193, 123162, 2022 | 15 | 2022 |
| Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis AP Pérez-Acevedo, FP Busardò, R Pacifici, G Mannocchi, M Gottardi, ... Pharmaceuticals 13 (12), 459, 2020 | 15 | 2020 |
| Hexahydrocannabinol pharmacology, toxicology, and analysis: the first evidence for a recent new psychoactive substance S Graziano, MR Varì, S Pichini, FP Busardò, T Cassano, A Di Trana Current neuropharmacology 21 (12), 2424, 2023 | 13 | 2023 |
| Liquid chromatography high-resolution mass spectrometry in forensic toxicology: what are the specifics of method development, validation and quality assurance for comprehensive … SMR Wille, B Desharnais, S Pichini, AD Trana, FP Busardò, ... Current Pharmaceutical Design 28 (15), 1230-1244, 2022 | 13 | 2022 |
| Monitoring prenatal exposure to buprenorphine and methadone A Di Trana, N La Maida, R Tittarelli, MA Huestis, S Pichini, FP Busardò, ... Therapeutic Drug Monitoring 42 (2), 181-193, 2020 | 13 | 2020 |
| New trends of substance abuse: looking for new psychotropic effects of chem sex drugs, cognitive enhancers, and new psychoactive substances S Pichini, A Di Trana, M Torrens, N Scherbaum, S Zaami Frontiers in psychiatry 11, 612192, 2020 | 11 | 2020 |
| β′-Phenylfentanyl metabolism in primary human hepatocyte incubations: identification of potential biomarkers of exposure in clinical and forensic toxicology P Brunetti, AF Lo Faro, A Di Trana, A Montana, G Basile, J Carlier, ... Journal of Analytical Toxicology 46 (9), e207-e217, 2022 | 10 | 2022 |
| Synthetic benzimidazole opioids: the emerging health challenge for European drug users A Di Trana, S Pichini, R Pacifici, R Giorgetti, FP Busardò Frontiers in psychiatry 13, 858234, 2022 | 10 | 2022 |
| Fentanyl analogues potency: What should be known A Di Trana, A Del Rio La Clinica Terapeutica 171 (5), 2020 | 10 | 2020 |
| Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances A Di Trana, D Berardinelli, E Montanari, P Berretta, G Basile, MA Huestis, ... International Journal of Molecular Sciences 23 (23), 14619, 2022 | 9 | 2022 |
